Anti-Allergy Medicines — Medication Guide, Uses & Safety — Uses, Dosage & Side Effects | MyMedicPlus

Anti-allergy medicines prevent or relieve the symptoms of allergic reactions triggered by the immune system's hypersensitivity response to allergens such as pollen, dust mites, pet dander, food proteins, insect venom, or medications. The most commonly used class is antihistamines, which block histamine — the primary chemical mediator released by mast cells and basophils during an allergic reaction. The drug class is divided into first-generation (sedating) antihistamines and second-generation (non-sedating) antihistamines. Other important anti-allergy drug classes include nasal corticosteroids (for sustained airway inflammation control), leukotriene receptor antagonists (montelukast), mast cell stabilizers (cromolyn sodium), oral and intranasal decongestants, and epinephrine (adrenaline) auto-injectors for the emergency treatment of anaphylaxis — the most severe, life-threatening form of allergic reaction. Regulatory bodies including the FDA, EMA, and national medicines agencies have approved these drugs for a range of allergic conditions.

Anti-allergy medicines are used across a wide spectrum of allergic conditions. First-line indications include allergic rhinitis (hay fever — seasonal or perennial), urticaria (hives), allergic conjunctivitis (eye allergy causing itching and tearing), and allergic eczema (atopic dermatitis). They are also used for insect sting and bite reactions, mild-to-moderate food allergy symptoms (itching, hives), drug allergy symptoms, and allergic asthma triggered by sensitized allergens. Antihistamines are commonly prescribed or recommended by general practitioners, allergists, and pediatricians. Nasal corticosteroids (fluticasone, mometasone) are prescribed for moderate-to-severe allergic rhinitis. Leukotriene antagonists (montelukast) are used as add-on therapy for rhinitis and allergic asthma. Epinephrine auto-injectors (EpiPen) are prescribed for patients at risk of anaphylaxis from food, insect, or drug allergens. Pre-emptive dosing before anticipated allergen exposure is also a common practice.

Antihistamines competitively block H1 histamine receptors on cells in the nose, eyes, skin, and airways, preventing histamine from triggering the hallmark allergy symptoms of itching, sneezing, watery eyes, and runny nose. First-generation antihistamines (e.g. chlorphenamine, diphenhydramine, promethazine) readily cross the blood-brain barrier because they are lipophilic, which accounts for their significant sedative and anticholinergic side effects. Second-generation antihistamines (e.g. cetirizine, loratadine, fexofenadine, desloratadine) are less lipophilic, penetrate the brain poorly, and are therefore minimally sedating — making them the preferred choice for daytime use. Nasal corticosteroids reduce inflammatory cell infiltration and cytokine release in the nasal mucosa, providing long-lasting suppression of nasal allergy symptoms. Montelukast (leukotriene antagonist) blocks cysteinyl leukotriene receptors, reducing bronchospasm and nasal inflammation. Epinephrine rapidly reverses anaphylaxis by stimulating alpha-1 receptors (vasoconstriction, reversing hypotension) and beta-2 receptors (bronchodilation, reversing airway obstruction).

Common non-sedating oral antihistamines for adults: cetirizine 10 mg once daily; loratadine 10 mg once daily; fexofenadine 120 mg once daily (for rhinitis) or 180 mg once daily (for urticaria); desloratadine 5 mg once daily. Sedating antihistamine: chlorphenamine 4 mg every 4–6 hours (max 24 mg/day adults); diphenhydramine 25–50 mg every 4–6 hours. Nasal corticosteroids (e.g. fluticasone propionate): 2 sprays in each nostril once daily, reduced to 1 spray once daily when controlled. Montelukast: 10 mg once daily at night in adults. Epinephrine auto-injector (EpiPen): 0.3 mg intramuscularly injected into the outer thigh muscle during anaphylaxis — seek emergency medical care immediately after use. Children's doses are weight- and age-based. Always follow your doctor's or allergist's prescription instructions precisely.

First-generation (sedating) antihistamines cause significant drowsiness (affecting up to 30–50% of users), dry mouth, blurred vision, urinary retention, constipation, tachycardia, and impaired cognitive function and coordination — patients must not drive or operate machinery. Alcohol and sedatives dangerously amplify these CNS depressant effects. Second-generation antihistamines cause minimal sedation and are strongly preferred for daytime use; cetirizine causes mild drowsiness in approximately 10% of users, while fexofenadine is almost entirely non-sedating. Nasal corticosteroids may cause local nasal dryness, crusting, and occasional minor epistaxis (nosebleeds); systemic absorption is minimal at recommended doses. Montelukast has been associated with neuropsychiatric events including nightmares, mood changes, and suicidal ideation — the FDA has added a black-box warning; discuss risk-benefit with your doctor. Oral decongestants (pseudoephedrine) can significantly raise blood pressure, increase heart rate, and cause insomnia — avoid in hypertension, heart disease, and hyperthyroidism. Nasal decongestant sprays (xylometazoline, oxymetazoline) cause rebound congestion (rhinitis medicamentosa) if used for more than 3–5 consecutive days.

Patients at risk of anaphylaxis — due to known allergy to bee or wasp stings, peanuts, tree nuts, shellfish, fish, milk, egg, or medications — must carry an epinephrine auto-injector at all times and know how to use it correctly. Antihistamines alone cannot treat anaphylaxis and must never be used as a substitute for or a reason to delay epinephrine administration. After epinephrine is given, call emergency services (911/999) immediately and proceed to the nearest emergency department for monitoring. Sedating antihistamines (chlorphenamine, diphenhydramine, promethazine) must never be combined with alcohol, opioid analgesics, benzodiazepines, or other CNS depressants due to the risk of profound respiratory depression and death. Montelukast carries an FDA black-box warning for neuropsychiatric side effects — monitor closely, especially in children and adolescents. First-generation antihistamines are contraindicated in angle-closure glaucoma, urinary retention, and BPH. Drug interactions: chlorphenamine interacts with MAOIs (potentially fatal); fexofenadine absorption is significantly reduced by grapefruit, orange, and apple juice — take with water only. Always disclose all allergy medications to every healthcare provider.